Partial volume effect (PVE)
A PET or SPECT scan can make small tumours or lesions look fainter than they really are, simply because the scanner cannot see fine detail perfectly; the true 'brightness' gets smeared out over a wider area, especially in objects smaller than about 1-2 cm.
Overview
The partial volume effect is the systematic underestimation of measured activity concentration in objects that are small relative to the spatial resolution of a PET or SPECT imaging system, caused by two combined phenomena: the finite spatial resolution of the scanner blurs the true activity distribution (a 3D convolution with the system's point-spread function), causing signal to 'spill out' of small hot lesions and background signal to 'spill in'; and the sampling of a continuous activity distribution onto a discrete voxel grid means boundary voxels contain a mixture of tissues (the tissue-fraction effect). Both effects become significant when an object's smallest dimension is below roughly two to three times the system's full-width-at-half-maximum (FWHM) spatial resolution, corresponding to roughly 6-15 mm for typical PET systems and roughly 14-25 mm for SPECT systems, which have poorer intrinsic resolution.
The practical consequence is a size-dependent, reproducible bias, not random noise: the smaller the lesion, the greater the underestimation of measured uptake (SUVmax or SUVmean) or, for post-therapy dosimetry, of the true absorbed dose. In one worked clinical example, SPECT-based lesion dosimetry for 177Lu therapy underestimated the true absorbed dose by more than 60% in a roughly 1 cm lesion and by more than 99% in a lesion only a few millimetres across.
Partial volume effect matters for radiopharmaceutical therapy dosimetry because small metastases, exactly the lesions most likely to be missed or under-dosed, are the ones most affected; it also affects diagnostic PET quantification, where small lymph nodes below about 10 mm read out with substantially lower SUV than their true uptake. Partial volume correction methods (recovery-coefficient-based, MRI- or CT-guided) can partly compensate but rarely restore full accuracy for sub-centimetre structures, and current guidance recommends excluding lesions below about 10 mm from quantitative analysis unless a validated correction method is applied.
- Detector ring
- Tracer uptake
- 511 keV photon pair
Showing the technology this term belongs to: PET (positron emission tomography).
Similar pages
not linked directly; found by shared links- TermTumour-to-background ratio (TBR)
Shares Standardised uptake value (SUV), Quantitative imaging biomarkers (RECIST, PERCIST, SUV, ADC).
- IdeaAI segmentation to make voxel-level radioligand dosimetry practical at scale
Shares Quantitative imaging biomarkers (RECIST, PERCIST, SUV, ADC), Radioligand dosimetry, Lutetium-177.
- TermDecay correction
Shares Radioligand dosimetry, SPECT & bone scan, PET (positron emission tomography).
- TechnologyTotal-body PET for screening and ultra-low-dose imaging
Shares Time-of-flight (TOF) PET, PET (positron emission tomography).
- TechnologyNuclear medicine and total-body PET hardware
Shares Time-of-flight (TOF) PET, SPECT & bone scan, PET (positron emission tomography).
- IdeaKidney-dosimetry-guided dosing as the default for PSMA radioligand therapy
Shares Radioligand dosimetry, Lutetium-177.
- PersonMichael Lassmann
Shares Radioligand dosimetry, Lutetium-177.
- IsotopeScandium-44
Shares Radioligand dosimetry, PET (positron emission tomography).